Key Statistics for 4282
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (JPY) (ttm)
|Est. EPS (JPY) (09/2013)
|Est. PEG Ratio
|Market Cap (M JPY)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (JPY)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 4282
- Net Income (M/JPY)
EPS Corporation provides clinical testing services to contract research organizations (CROs) who are in the pharmaceutical industry in Japan. The Company's services range from planning, monitoring, and analyzing study and clinical testing for development of new drugs. EPS also develops systems and provides data management as well as patent registration.
More Company Profile & Key Executives for 4282
|Yan HaoChairman||Shinro TashiroPresident|
|Shuzo OrihashiManaging Executive Officer||Kazuki SekiyaManaging Executive Officer|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries